Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-blockers vs 5-alpha Reductase Inhibitors

Urology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles